ImmuneOncia Therapeutics Inc
KOSDAQ:424870
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ImmuneOncia Therapeutics Inc
KOSDAQ:424870
|
KR |
|
Yash Pakka Limited
BSE:516030
|
IN |
|
T
|
Tochigi Bank Ltd
TSE:8550
|
JP |
|
G
|
Galileo Tech Ltd
TASE:GLTC
|
IL |
|
R
|
Robostar Co Ltd
KOSDAQ:090360
|
KR |
|
Y
|
Yamazaki Co Ltd
TSE:6147
|
JP |
|
D
|
Daito Me Holdings Co Ltd
TPEX:8455
|
KY |
|
Chordate Medical Holding AB (publ)
F:K1Z0
|
SE |
|
Active Energy Group PLC
F:BZH
|
UK |
|
A
|
Accelerate Property Fund Ltd
JSE:APF
|
ZA |
|
W
|
Wholetech System Hitech Ltd
TPEX:3402
|
TW |
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
MY |
|
Eden Research PLC
LSE:EDEN
|
UK |
|
P
|
Presidential Realty Corp
OTC:PDNLB
|
US |
|
T
|
Thriven Global Bhd
KLSE:THRIVEN
|
MY |
|
I
|
International Graphite Ltd
ASX:IG6
|
AU |
|
T
|
Tainan Enterprises Co Ltd
TWSE:1473
|
TW |
|
A
|
Alterity Therapeutics Ltd
NASDAQ:ATHE
|
AU |
|
C
|
Construction JSC 47
VN:C47
|
VN |
|
Coast Entertainment Holdings Ltd
F:MD8
|
AU |
|
A
|
Alticast Corp
KOSDAQ:085810
|
KR |
Bankruptcy Probability
ImmuneOncia Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ImmuneOncia Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
I
|
ImmuneOncia Therapeutics Inc
KOSDAQ:424870
|
261.5B KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
M
|
Metsera Inc
NASDAQ:MTSR
|
7.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
S
|
Samsung Epis Holdings Co Ltd
KRX:0126Z0
|
9T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Oruka Therapeutics Inc
NASDAQ:ORKA
|
5.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Definium Therapeutics Inc
NASDAQ:DFTX
|
5.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
Parabilis Medicines Inc
NASDAQ:PBLS
|
4.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
BillionToOne Inc
NASDAQ:BLLN
|
4.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
V
|
Veradermics Inc
NYSE:MANE
|
4.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Grail Inc
NASDAQ:GRAL
|
3.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| TW |
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
96.9B TWD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IN |
|
Rubicon Research Ltd
NSE:RUBICON
|
282.4B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ImmuneOncia Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ImmuneOncia Therapeutics Inc has total debt of 12.4m . This includes both short-term (0 ) and long-term (12.4m ) debt.
You can find a full breakdown on its Balance Sheet.
